Schistosomiasis Treatment Market - Global Industry Insights, and Opportunity Analysis, 2017–2025
Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. According to the World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People usually get infected during agriculture, domestic, and occupational activities, which exposes them to infected water resulting into immune reactions. Symptoms in intestinal schistosomiasis infected patient shows various symptoms such as, abdominal pain, diarrhea, liver and spleen enlargement, fibrosis of the bladder, and progressive damage of kidney. Other chronic symptoms includes blood in stool, blood in urea, genital lesions, nodules in vulva, seizures, paralysis, seminal vesicle, and vaginal bleeding. This symptoms could result into urogenital related schistosomiasis complications, such as bladder cancer, and long term irreversible consequences such as infertility. According to the World Health Organization (WHO), around 218 million people required preventive treatments for schistosomiasis in 2015 and more than 66.5 million people were reported as treated for schistosomiasis in the same year. Further, WHO states that the transmission of schistosomiasis was reported in 78 countries. Schistosomiasis treatment is a major concern due to lack of proper medication and vaccination. Preventive chemotherapy for schistosomiasis includes praziquantel, metrifonate, and oxamniquine.
Schistosomiasis is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of schistosomiasis, such as intestinal and urogenital. According to the World Health Organization (WHO) reports in 2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People usually get infected during agriculture, domestic, and occupational activities, which exposes them to infected water resulting into immune reactions. Symptoms in intestinal schistosomiasis infected patient shows various symptoms such as, abdominal pain, diarrhea, liver and spleen enlargement, fibrosis of the bladder, and progressive damage of kidney. Other chronic symptoms includes blood in stool, blood in urea, genital lesions, nodules in vulva, seizures, paralysis, seminal vesicle, and vaginal bleeding. This symptoms could result into urogenital related schistosomiasis complications, such as bladder cancer, and long term irreversible consequences such as infertility. According to the World Health Organization (WHO), around 218 million people required preventive treatments for schistosomiasis in 2015 and more than 66.5 million people were reported as treated for schistosomiasis in the same year. Further, WHO states that the transmission of schistosomiasis was reported in 78 countries. Schistosomiasis treatment is a major concern due to lack of proper medication and vaccination. Preventive chemotherapy for schistosomiasis includes praziquantel, metrifonate, and oxamniquine.
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Schistosomiasis</strong> <strong>Treatment</strong> <strong>Market</strong>-<br />
GLOBAL INDUSTRY INSIGHTS, TRENDS,<br />
OUTLOOK, AND OPPORTUNITY ANALYSIS, 2017-<br />
2025<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Schistosomiasis</strong> <strong>Treatment</strong> <strong>Market</strong> – Overview<br />
<strong>Schistosomiasis</strong> is a disease caused by infection with freshwater parasitic worms. It can be acute or chronic<br />
infection mainly caused by parasitic worm’s blood flukes (trematode worms). There are two forms of<br />
schistosomiasis, such as intestinal <strong>and</strong> urogenital. According to the World Health Organization (WHO) reports in<br />
2017, urogenital schistosomiasis is a high risk factor for the transmission of HIV infection in women. People<br />
usually get infected during agriculture, domestic, <strong>and</strong> occupational activities, which exposes them to infected<br />
water resulting into immune reactions. Symptoms in intestinal schistosomiasis infected patient shows various<br />
symptoms such as, abdominal pain, diarrhea, liver <strong>and</strong> spleen enlargement, fibrosis of the bladder, <strong>and</strong><br />
progressive damage of kidney. Other chronic symptoms includes blood in stool, blood in urea, genital lesions,<br />
nodules in vulva, seizures, paralysis, seminal vesicle, <strong>and</strong> vaginal bleeding. This symptoms could result into<br />
urogenital related schistosomiasis complications, such as bladder cancer, <strong>and</strong> long term irreversible consequences<br />
such as infertility. According to the World Health Organization (WHO), around 218 million people required<br />
preventive treatments for schistosomiasis in 2015 <strong>and</strong> more than 66.5 million people were reported as treated for<br />
schistosomiasis in the same year. Further, WHO states that the transmission of schistosomiasis was reported in 78<br />
countries. <strong>Schistosomiasis</strong> treatment is a major concern due to lack of proper medication <strong>and</strong> vaccination.<br />
Preventive chemotherapy for schistosomiasis includes praziquantel, metrifonate, <strong>and</strong> oxamniquine.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Schistosomiasis</strong> <strong>Treatment</strong> <strong>Market</strong>: Taxonomy<br />
On the basis of organ, the <strong>Schistosomiasis</strong> treatment market is segmented into:<br />
Intestinal<br />
Urogenital<br />
On the basis of species, the <strong>Schistosomiasis</strong> treatment market is segmented into:<br />
Schistosoma mansoni<br />
Schistosoma japonicum<br />
Schistosoma mekongi<br />
Schistosoma guineensis<br />
Schistosoma haematobium<br />
On the basis of drug type, the <strong>Schistosomiasis</strong> treatment market is segmented into:<br />
Praziquantel<br />
Metrifonate<br />
Biltricide<br />
Oxamniquine<br />
Others<br />
Request a sample copy of this report: https://www.coherentmarketinsights.com/insight/request-sample/889<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
REPORT DESCRIPTION<br />
<strong>Schistosomiasis</strong> <strong>Treatment</strong> <strong>Market</strong>: Key Players<br />
Major players involved in the global schistosomiasis treatment market include:<br />
●<br />
Chemos GmbH & Co. KG<br />
●<br />
Shin Poong Pharma.Co. Ltd.<br />
●<br />
Meher Distributors Pvt. Ltd.<br />
●<br />
Merck & Co.<br />
●<br />
Salvensis<br />
●<br />
Bayer AG<br />
●<br />
LondonPharma Ltd<br />
●<br />
Merck & Co., Inc.<br />
●<br />
3S Corporation Kancera AB<br />
Click here to know more about this report:<br />
https://www.coherentmarketinsights.com/ongoing-insight/schistosomiasis-treatment-market-889<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
ABOUT US<br />
Coherent <strong>Market</strong> <strong>Insights</strong> is a global market intelligence <strong>and</strong> consulting<br />
organization focused on assisting its plethora of clients achieve transformational<br />
growth by helping them make critical business decisions. We are headquartered in<br />
India, with an office at the global financial capital in the U.S. Our client base<br />
includes players from across all business verticals in over 150 countries worldwide.<br />
We are uniquely positioned to help businesses around the globe deliver practical<br />
<strong>and</strong> lasting results through various recommendations about operational<br />
improvements, technologies, emerging market trends <strong>and</strong> new working methods.<br />
We offer both customized <strong>and</strong> syndicated market research reports that help our<br />
clients create visionary growth plans to provide traction to their business. We<br />
meticulously study emerging trends across various industries at both the global<br />
<strong>and</strong> regional levels to identify new opportunities for our clientele.<br />
SERVICES<br />
INDUSTRY ANALYSIS<br />
MARKET INTELLIGENCE<br />
SERVICES<br />
CUSTOMIZED<br />
RESEARCH<br />
CONSULT STUDIES<br />
SYNDICATED RESEARCH<br />
COUNTRY SPECIFIC<br />
STUDIES<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
Industries we cater<br />
SECTOR COVERAGE<br />
Healthcare<br />
BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT<br />
MEDICAL DEVICES<br />
MEDICAL IMAGING<br />
Chemicals & Materials<br />
PHARMACEUTICAL<br />
Bulk Chemicals Advanced Materials Speciality <strong>and</strong> Fine<br />
Chemicals<br />
Green Chemicals<br />
Food Ingredients<br />
Cosmetic<br />
Ingredients<br />
Polymers &<br />
Resins<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
ABOUT COHERENT MARKET INSIGHTS<br />
KEY STATS<br />
100+<br />
<strong>Insights</strong> Published Per Year<br />
150+<br />
Consulting Projects Till Date<br />
125+<br />
Clients Worldwide Per Year<br />
RESEARCH SOLUTIONS<br />
CONSULT<br />
PROJECTS<br />
SURVEY<br />
RESEAR<br />
CH<br />
FEASIBILITY<br />
STUDIES<br />
EXCEL<br />
FORECAST<br />
DATABASE<br />
GLOBAL<br />
REPORTS<br />
COUNTRY<br />
ANALYSIS<br />
CUSTOMIZED<br />
SOLUTIONS<br />
COMPETITIVE<br />
ASSESSMENT<br />
110+<br />
Analysts <strong>and</strong> Contract Consultants<br />
TECHNOLOGY<br />
SNIPPETS<br />
Coherent <strong>Market</strong> <strong>Insights</strong> excels at offering unmatched actionable market intelligence across various industry verticals, including<br />
chemicals, healthcare, <strong>and</strong> food & beverages, to name a few. We implement holistic market research methodology in order to result in<br />
the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various<br />
industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely<br />
designed <strong>and</strong> highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed<br />
markets <strong>and</strong> also key inputs to help them tap into emerging markets <strong>and</strong> exploit the plethora of opportunities posed therein.<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
THANK YOU<br />
To know more about us, visit our website:<br />
www.coherentmarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@coherentmarketinsights.com<br />
For other queries contact:<br />
Mr. Shah<br />
(Manager - Business Development)<br />
Coherent <strong>Market</strong> <strong>Insights</strong><br />
sales@coherentmarketinsights.com<br />
+1-206-701-6702<br />
© Coherent market <strong>Insights</strong>. All Rights Reserved
Change language